Robotic Endovascular Systems Market Gaining Traction with Emerging Opportunities
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Robotic Assisted Endovascular Systems Market During The 2026–2030 Period?
The market size for robotic assisted endovascular systems has demonstrated strong growth in recent years. It is projected to increase from $32.01 billion in 2025 to $34.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The expansion observed in the historical period is attributable to an increase in cardiovascular disease cases, the growth of catheter-based interventions, the expansion of interventional radiology units, a rising preference for minimally invasive surgery, and improvements in vascular imaging.
The market for robotic assisted endovascular systems is projected to experience substantial expansion in the coming years. This market is predicted to reach $48.94 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This anticipated growth during the forecast period can be linked to several factors, including the expansion of robotic vascular laboratories, an increasing need for precision-guided interventions, the broadening scope of neurovascular robotic procedures, enhanced capabilities in remote surgery, and elevated hospital spending on robotic suites. Key trends expected over the forecast period encompass advancements in robotic catheter navigation, a growing acceptance of minimally invasive vascular procedures, the development of imaging-guided robotic platforms, an uptick in the application of remote robotic intervention, and the incorporation of precision vascular control systems.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33306&type=smp
Which Core Factors Are Supporting The Expansion Of The Robotic Assisted Endovascular Systems Market?
The increasing occurrence of cardiovascular and neurovascular diseases is projected to boost the expansion of the robotic-assisted endovascular systems market moving forward. These conditions, which involve the heart, blood vessels, and brain circulation, encompass issues like coronary artery disease, stroke, and cerebral aneurysms, and are a primary global contributor to mortality and extended disability. The rise in cardiovascular and neurovascular diseases is attributable to an aging populace alongside a greater incidence of lifestyle-associated risk factors such as obesity, high blood pressure, and lack of physical activity. Robotic-assisted endovascular systems are instrumental in managing these diseases by allowing for highly precise, minimally invasive navigation within blood vessels, thereby enhancing treatment accuracy, patient safety, and clinical results for intricate vascular procedures. As an illustration, in January 2024, the American Heart Association, a US-based non-profit organization, reported that the age-adjusted death rate due to cardiovascular disease escalated to 233.3 per 100,000 in 2024, marking a 4.0% rise from 224.4 per 100,000 in 2023. Consequently, the growing prevalence of cardiovascular and neurovascular diseases is fueling the growth of the robotic-assisted endovascular systems market.
Which Segment Divisions Form The Structure Of The Robotic Assisted Endovascular Systems Market?
The robotic assisted endovascular systems market covered in this report is segmented –
1) By Component: Hardware; Software; Services
2) By Product: Robotic Catheter Systems; Robotic Guidewire Systems; Robotic Angioplasty Systems; Other Products
3) By Technology: Robotic Catheter Systems; AI-Assisted Navigation Systems; Imaging-Guided Robotic Platforms; Haptic Feedback Systems; Autonomous Robotic Systems
4) By Application: Coronary Interventions; Peripheral Vascular Interventions; Neurovascular Interventions; Other Applications
5) By End-User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Research And Academic Institutes; Other End-Users
Subsegments:
1) By Hardware: Robotic Control Units; Robotic Catheter Systems; Navigation Consoles; Imaging Integration Modules; Surgical Instrument Arms
2) By Software: Navigation Software Platforms; Imaging Processing Software; Procedure Planning Software; Data Management Software; Clinical Decision Support Software
3) By Services: Installation Services; Maintenance And Repair Services; Training And Education Services; System Upgradation Services
Which Trends Are Affecting The Robotic Assisted Endovascular Systems Market Framework?
Major companies operating in the robotic assisted endovascular systems market are focusing on integrating robotics with advanced imaging and navigation systems, such as fully remote endovascular robotic platforms. This integration aims to improve procedural precision, enable complex vascular navigation, and expand access to specialist care. Fully remote endovascular robotic platforms are defined as robotic systems that combine real-time fluoroscopic imaging with preoperative CT and MRI data to guide the robotic manipulation of catheters and guidewires during endovascular procedures, while allowing clinicians to operate from a remote console. For instance, in October 2025, Remedy Robotics, a US-based medical technology company, introduced the Remedy N1 System, an endovascular surgical robotic platform designed to support fully remote neurointerventional procedures. This system is engineered to enhance accuracy and clinical workflow by integrating automated CT and MRI image preprocessing with live fluoroscopic imaging for real-time navigation. It also enables simultaneous robotic control of up to four endovascular devices and includes a portable operator console with secure audiovisual connectivity to support remote procedural execution.
Who Are The Companies Shaping The Robotic Assisted Endovascular Systems Market Landscape?
Major companies operating in the robotic assisted endovascular systems market are Johnson & Johnson, Siemens Healthineers AG, Corindus Vascular Robotics Inc., Cordis Corporation, MicroPort Scientific Corporation, Hansen Medical Inc., Robocath S.A.S., Magnetecs Corporation, Cathbot Robot Co. Ltd., EKOS Corporation, Stereotaxis Inc., Imperative Care Inc., WeMed Medical Technology Co. Ltd., Lombard Medical Limited, Endovascular Robotics Inc., SS Innovations International Inc., Visionary Medicare Co. Ltd., Vantis Vascular Inc., Microbot Medical Inc., Sentante Ltd.
Access The Complete Robotic Assisted Endovascular Systems Market Report:
Which Regional Market Leads The Robotic Assisted Endovascular Systems Market?
Europe was the largest region in the robotic assisted endovascular systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic assisted endovascular systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Robotic Assisted Endovascular Systems Market Report for Deeper Competitive Insights
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
